Initial experience of robot-assisted partial nephrectomy with Hugo™ RAS system: implications for surgical setting.

Medtronic Hugo RAS system Nephron sparing surgery Renal cancer Robot-assisted partial nephrectomy Robotic surgery

Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 30 01 2023
accepted: 30 01 2023
medline: 8 5 2023
pubmed: 28 2 2023
entrez: 27 2 2023
Statut: ppublish

Résumé

Hugo™ RAS system is one of the most promising new robotic platforms introduced in the field of urology. To date, no data have been provided on robot-assisted partial nephrectomy (RAPN) performed with Hugo™ RAS system. The aim of the study is to describe the setting and report the performance of the first series of RAPN performed with Hugo™ RAS system. Ten consecutive patients who underwent RAPN at our Institution between February and December 2022 were prospectively enrolled. All RAPN were performed transperitoneally with a modular four-arm configuration. The main outcome was to describe the operative room setting, trocar placement and the performance of this novel robotic platform. Pre, intra and post-operative, variables were recorded. A descriptive analysis was performed. Seven patients underwent RAPN for right-side and three for left-side masses. Median tumor size and PADUA score were 3 (2.2-3.7) cm and 9 (8-9), respectively. Median docking and console time were 9.5 (9-14) and 138 (124-162) minutes, respectively. Median warm ischemia time was 13 (10-14) minutes, and one case was performed clamp-less. Median estimated blood loss was 90 (75-100) mL. One major complication (Clavien-Dindo 3a) occurred. No case of positive surgical margin was recorded. This is the first series to prove the feasibility of Hugo™ RAS system in the setting of RAPN. These preliminary results may help new adopters of this surgical platform to identify critical steps of robotic surgery with this platform and explore solutions before in-vivo surgery.

Identifiants

pubmed: 36847815
doi: 10.1007/s00345-023-04336-9
pii: 10.1007/s00345-023-04336-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1085-1091

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Rassweiler JJ, Autorino R, Klein J et al (2017) Future of robotic surgery in urology. BJU Int 120(6):822–841
doi: 10.1111/bju.13851 pubmed: 28319324
Liatsikos E, Tsaturyan A, Kyriazis I et al (2022) Market potentials of robotic systems in medical science: analysis of the Avatera robotic system. World J Urol 40(1):283–289
doi: 10.1007/s00345-021-03809-z pubmed: 34424374
Ficarra V, Novara G, Secco S et al (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56(5):786–793
doi: 10.1016/j.eururo.2009.07.040 pubmed: 19665284
Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
doi: 10.7326/0003-4819-150-9-200905050-00006 pubmed: 19414839 pmcid: 2763564
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
Farinha R, Breda A, Porter J et al (2022) RAPN-Delphi surgeons group. International expert consensus on metric-based characterization of robot-assisted partial nephrectomy. Eur Urol Focus S2405–4569(22):00226–00227
Farinha R, Puliatti S, Mazzone E et al (2022) Potential contenders for the leadership in robotic surgery. J Endourol 36(3):317–326
doi: 10.1089/end.2021.0321 pubmed: 34579555
Mottaran A, Paciotti M, Bravi CA et al (2022) Robot-assisted simple prostatectomy with the novel HUGO™ RAS system: feasibility, setting, and perioperative outcomes. Minerva Urol Nephrol. https://doi.org/10.23736/S2724-6051.22.05031-5
doi: 10.23736/S2724-6051.22.05031-5 pubmed: 36286397
Mottaran A, Bravi C, Sarchi L et al (2022) Robot-assisted sacropexy with the novel HUGO™ RAS system: initial experience and surgical setup at a tertiary referral robotic center. J Endourol. https://doi.org/10.1089/end.2022.0495
doi: 10.1089/end.2022.0495 pubmed: 36053673
Larkins KM, Mohan HM, Gray M et al (2022) Transferability of robotic console skills by early robotic surgeons: a multi-platform crossover trial of simulation training. J Robot Surg. https://doi.org/10.1007/s11701-022-01475-w
doi: 10.1007/s11701-022-01475-w pubmed: 36520267 pmcid: 10076398
Sarchi L, Mottaran A, Bravi CA et al (2022) Robot-assisted radical prostatectomy feasibility and setting with the Hugo™ robot-assisted surgery system. BJU Int 130(5):671–675
doi: 10.1111/bju.15819 pubmed: 35689414
Bravi CA, Paciotti M, Sarchi L et al (2022) Robot-assisted radical prostatectomy with the Novel Hugo robotic system: initial experience and optimal surgical set-up at a tertiary referral robotic center. Eur Urol 82(2):233–237
doi: 10.1016/j.eururo.2022.04.029 pubmed: 35568597
Ragavan N, Bharathkumar S, Chirravur P et al (2022) Evaluation of Hugo RAS system in major urologic surgery: our initial experience. J Endourol 36(8):1029–1035
doi: 10.1089/end.2022.0015 pubmed: 35156838

Auteurs

Andrea Gallioli (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Alessandro Uleri (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain. alessandrouleri@outlook.it.

Josep Maria Gaya (JM)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Angelo Territo (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Julia Aumatell (J)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Paolo Verri (P)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Giuseppe Basile (G)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Sofia Fontanet (S)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Alessandro Tedde (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Pietro Diana (P)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Edgar Suquilanda (E)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Ferran Algaba (F)

Department of Pathology, Fundació Puigvert, Autonomous University of Barcelona, Barcelona, Spain.

Joan Palou (J)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Alberto Breda (A)

Department of Urology, Fundació Puigvert, Autonomous University of Barcelona, Carrer de Cartagena, 350, 08025, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH